Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MM-111 |
Synonyms | |
Therapy Description |
MM-111 is a bispecific antibody that binds simultaneously to ERBB2 (HER2) and ERBB3 (HER3) which may block signaling and inhibit tumor growth (PMID: 22248472, PMID: 30079142). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MM-111 | MM 111|MM111 | HER2 (ERBB2) Antibody 76 HER3 (ERBB3) Antibody 23 | MM-111 is a bispecific antibody that binds simultaneously to ERBB2 (HER2) and ERBB3 (HER3) which may block signaling and inhibit tumor growth (PMID: 22248472, PMID: 30079142). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|